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Abstract
Introduction: Noninvasive fetal heart rate monitoring using transabdominal fetal 
electrocardiographic detection is now commercially available and has been dem-
onstrated to be an effective alternative to traditional Doppler ultrasonographic 
techniques. Our objective in this study was to compare the results of computer-
ized identification of fetal heart rate patterns generated by ultrasound-based and 
transabdominal fetal electrocardiogram-based techniques with simultaneously ob-
tained fetal scalp electrode-derived heart rate information.
Material and methods: We applied an objective computer-based analysis for recogni-
tion of fetal heart rate patterns (Monica Decision Support) to data obtained simultane-
ously from a direct fetal scalp electrode, Doppler ultrasound, and the abdominal-fetal 
electrocardiogram techniques. This allowed us to compare over 145 hours of fetal heart 
rate patterns generated by the external devices with those derived from the scalp elec-
trode in 30 term singleton uncomplicated pregnancies during labor. The direct fetal 
scalp electrode is considered to be the most accurate and reliable technique used in 
current clinical practice, and was, therefore, used as the standard for comparison. The 
program quantified the baseline heart rate, long- and short-term variability. It indicated 
when an acceleration or deceleration was present and whether it was large or small.
Results: Ultrasound was associated with significantly greater deviations from the 
fetal scalp electrode results than the abdominal fetal electrocardiogram technique in 
recognizing the correct baseline heart rate, its variability, and the presence of small 
and large accelerations and small decelerations. For large decelerations the two ex-
ternal methods were each not significantly different from the scalp electrode results.
Conclusions: Noninvasive fetal heart rate monitoring using maternal abdominal wall 
electrodes to detect fetal cardiac activity more reliably reproduced the computerized 
analysis of heart rate patterns derived from a direct fetal scalp electrode than did 
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1  | INTRODUC TION
Several investigators have shown that noninvasive transabdominal 
fetal electrocardiogram (ECG) monitoring is technically feasible and 
of clinical value.1-8 We demonstrated previously that intrapartum fetal 
heart rate (FHR) detection using fetal ECG signals obtained by maternal 
abdominal surface electrodes (afECG) was more accurate and reliable 
than external ultrasound (US)-based monitoring when each external 
technique was compared with FHR data obtained simultaneously 
from a fetal scalp electrode (FSE).8 That study assessed the ability of 
the two types of external monitoring to identify each fetal heartbeat 
detected by the FSE. It did not evaluate directly the accuracy of the 
external devices in identifying the FHR baseline, its variability, or the 
presence of accelerations and decelerations, central features of FHR 
pattern interpretation. Moreover, although a close correspondence 
was demonstrated in heart beat identification between afECG and 
FSE-derived data, the specific hypothesis that afECG is not inferior to 
traditional US-based monitoring in identifying FHR patterns (baseline 
FHR, variability, decelerations, and accelerations) was not tested.
To address this issue we applied a standardized computer-based 
approach for recognition of FHR patterns to data obtained simulta-
neously from a direct FSE, US, and the afECG technique. We used 
a computer-based approach to eliminate concerns about inter- and 
intra-observer variability. We compared FHR patterns generated by 
the external devices to those from the FSE. The FSE is considered 
the most accurate and reliable technique used in current practice, 
and was, therefore, used as the standard for comparison. The pro-
gram quantified the baseline FHR, and long- and short-term variabil-
ity, and it noted the presence and magnitude of accelerations and 
decelerations. Although most of these terms are used by clinicians to 
assess fetal well-being, for the purposes of this study we used them 
solely to describe the morphology of the FHR tracings, and not to 
infer anything about fetal condition.
2  | MATERIAL AND METHODS
We undertook a secondary analysis of data from a prospective 
3-center trial designed to determine the performance of 2 modes 
of external FHR monitoring (afECG and US) compared with informa-
tion obtained from an FSE.8 For this report we examined data from 
30 patients of one hospital (Queens Hospital Center, Jamaica, NY, 
USA) in the parent study. The hospital used the Model 50XM system 
(Philips Healthcare, Andover, MA, USA) for standard FHR monitor-
ing in all participants. The study design required the simultaneous 
use of 3 methods of FHR detection in each participant (afECG, US, 
and FSE). At the time of the study the afECG monitor (Model AN24; 
Monica Healthcare Ltd, Nottingham, UK) was being evaluated by the 
US Food and Drug Administration; it has since become commercially 
available.
In the parent investigation, 36 women entered the trial at 
the study hospital. We analyzed 30 of these in the first stage of 
labor; 24 were studied in the second stage. Six potential partici-
pants were excluded because the first-stage monitoring period for 
the 3 coincident tracings was <30 minutes (4 participants), or the 
US transducer malfunctioned, leaving an uninterpretable tracing 
(2 participants).
Each woman had a singleton term (≥37 weeks) pregnancy in 
cephalic presentation and was recruited early in spontaneous 
labor, or when she presented for labor induction. Each was mon-
itored initially with the US technique. The tracing from the US 
monitor was available for clinical decision-making. The trans-
ducer position was adjusted as necessary by the attendant nurse 
every 20-30 minutes. The 5 afECG electrodes were applied to the 
maternal abdomen when it was determined that the US device was 
working appropriately. Data from the afECG were not visible to 
the care team.
An FSE was inserted later in labor in some patients if clinically 
indicated. The 30 women in whom simultaneous tracings from all 
3 monitors were available for at least 30 minutes were the study 
participants.
FHR information from the US and the afECG monitors along with 
that from the FSE were transmitted to a bedside computer for anal-
ysis. No externally derived FHR data were visible to the care team 
once the FSE was applied, the US record was evaluated at least every 
20–30 minutes by a research assistant who repositioned the trans-
ducer if necessary.
traditional ultrasound-based monitoring. Abdominal-fetal electrocardiogram should, 
therefore, be considered a primary option for externally monitored patients.
K E Y W O R D S
Doppler ultrasound, electronic fetal monitoring, fetal heart rate monitoring, fetal heart 
rate variability, fetal scalp electrode, intrapartum fetal heart rate, transabdominal fetal 
electrocardiogram monitoring
Key Message
Maternal transabdominal fetal electrocardiogram-based 
heart rate monitoring provided a more accurate depiction 
of heart rate variability, accelerations, and decelerations 
than ultrasound-based monitoring.
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2.1 | Data collection and analysis
A software algorithm that can accurately identify FHR pattern char-
acteristics was proposed by Dawes, Moulden, and Redman.9-18 Their 
validated approach has been used in several studies of both an-
tepartum and intrapartum FHR monitor tracings.14,15,19-23 Engineers 
at Monica Healthcare, Ltd. created an algorithm (Monica Decision 
Support [MDS]) based on the principles established by Dawes and 
his colleagues (and as published by Dobbe et al)24 and it was applied 
to assess the FHR patterns in our study. This algorithm was validated 
using a series of 87 hours of FHR data by the Divisie Perinatologie en 
Gynaecologie UMCU Utrecht (Utrecht, The Netherlands). This ap-
proach allowed us to examine the FHR patterns electronically in a 
uniform manner, avoiding the subjective observer bias that can con-
found consistent interpretation.
In order to generate the MDS parameters, FHR data were or-
ganized before analysis into 3.75-second epochs. The mean FHR 
(FHRav(i)) in beats/minute (bpm) in each epoch was converted to a 
pulse interval in milliseconds for analysis, ie, Tav(i) = 60 000/FHRav(i). 
The software then applied a rejection algorithm to each FHR pat-
tern. FHRav(i) values <30 or >200 bpm and any Tav(i) value >1.55 or 
<0.6 times the average of the preceding three Tav(i) values were ex-
cluded. Also, any 30-minute window that contained <15 minutes 
of FHR data was not analyzed. After applying the rejection algo-
rithm we identified the baseline FHR by deploying an exponential 
low-pass smoothing filter24 having coefficients that resulted in a 
cut-off frequency of 1/600 Hz. The resulting time constant pro-
vided a slowly varying heart rate from which prominent changes 
(ie, accelerations and decelerations, the characteristics of which are 
described below) were removed, leaving behind the baseline FHR. 
Otherwise stated, the baseline FHR is the average FHR excluding 
accelerations and decelerations over a 30-minute period referred 
to below as a “frame.” Our software also quantified long-term and 
short-term variability, and noted the presence of accelerations and 
decelerations.
Long-term variability (LTV) was assessed by determining over each 
minute the minute range, which is the absolute difference between 
the longest and shortest 3.75-second epoch pulse interval (Tav(i)), ex-
pressed in milliseconds over each sequential minute of baseline trac-
ing. Minutes with more than 10 seconds of signal loss or that contained 
any part of a deceleration were excluded from LTV analysis. Then, the 
average LTV value over each 30-minute frame was calculated for anal-
ysis, thus generating the “mean minute range.”
Short-term variability (STV) was measured by analyzing25 the 
pulse interval of each 3.75-second epoch. The absolute difference 
from one epoch’s pulse interval (Tav(i)) to the immediately following 
epoch’s pulse interval (Tav(i+1)) expresses the short-term variation. 
Over 1 minute an average short-term variation is derived from these 
absolute differences. Then in each 30-minute frame the average 
STV was calculated and used in our analyses.
FHR accelerations and decelerations were identified by devi-
ations from the baseline. A small acceleration was recorded when 
there was a rise in FHR from baseline of >10 bpm but ≤ 15 bpm that 
lasted >15 seconds; a large acceleration required a rise of more than 
15 bpm and a duration of >15 seconds.
A small deceleration was noted when the FHR dropped be-
tween 10 and 20 beats on average for 60 seconds, or fell more than 
20 beats from the baseline for 30 seconds. A large deceleration 
had a drop of at least 20 beats from baseline and a duration of at 
least 60 seconds or at least 40 beats for 30 seconds. The number 
of large and small decelerations and accelerations detected in each 
30-minute block of the FHR tracing was compared between meth-
ods of FHR detection. A false-positive acceleration or deceleration 
was one that was noted on an external method but not by the FSE; 
conversely, a false-negative acceleration or deceleration was rec-
ognized by the FSE but not by the comparison external device.
2.2 | Statistical analyses
The FHR data from all three sources were synchronized to within 
0.25 seconds before analysis. As noted above, the FHR values over 
each 3.75-second epoch were averaged into a single FHR value for that 
epoch; therefore, there were 16 FHR epoch values in every minute.
Using the MDS algorithm we extracted the baseline heart rate, 
STV, LTV, and the number of accelerations and decelerations in the 
simultaneous FHR recordings for each patient over all 30-minute 
frames in the first and second stages of labor. The median number 
of frame intervals analyzed per patient in stage I was 5, interquartile 
range 2–9, and in stage II was 3, interquartile range 2–4. In total for 
stage I and II there were 263 frames and 82 frames for afECG and 
228 frames and 85 frames for US.
For each participant we identified all paired frame data points, ie, 
those in which the FSE standard and the comparison external mon-
itor extracted an FHR analysis term. The paired data were used to 
determine differences between the distributions of data in the study 
groups. We calculated two sets of results for each participant: one 
compared the afECG against the FSE; the second compared the US 
method against the FSE. In each case the comparisons were made of 
the errors in the measurements, ie, the difference between the stan-
dard FSE value and the external value. Hence, the larger the error 
value, the greater the external device measurement deviated from 
that of the FSE. Because the distributions of these error measure-
ments were not normal, we compared them using the nonparametric 
Wilcoxon signed-rank test.
Accuracy of the external monitoring modes in identifying each FHR 
parameter in comparison with the FSE standard was also assessed by 
Bland-Altman analysis, a standard approach to determining the degree 
of agreement between 2 measurements. We used the predicate stan-
dard FSE value on the horizontal axis and the difference between the 
comparison device and the FSE on the vertical axis.25-27 In this manner 
a regression of the results from each pair of devices could be deter-
mined. This provided bias and limit of agreement values for each FHR 
data set comparison (FSE vs. afECG; FSE vs. US). The spread of values 
around the regression line is expressed mathematically by their root 
mean square error, limits of agreement, and bias.
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A Z-test for difference of proportions was used to compare the 
rates of false-positive and false-negative accelerations and deceler-
ations between monitoring modalities.
The statistical processing software deployed was IBM SPSS 
Statistics v. 24.0 (IBM Corp; Armonk, NY, USA). Matlab R2016A (The 
MathWorks, Natick, MA, USA) was used to create graphic Bland-
Altman and box plots. All analyses were performed for all measured pa-
rameters on the complete pooled data from each monitoring modality.
2.3 | Ethical approval
The original study was approved by the Institutional Review Board of 
each participating institution, and conformed to the guidelines of the 
World Medical Association Declaration of Helsinki. For this report 
we examined data from 30 patients of one hospital (Queens Hospital 
Center, Jamaica, NY, USA) from the parent study. The Institutional 
Review Board of the Mount Sinai (NY) Medical Center approved the 
protocol (study #09-2213) on 5 January 2010.
3  | RESULTS
3.1 | Overall sample attributes
The gestational age (mean ± SD) of the participants was 
39.4 ± 1.1 wk; maternal age was 25.9 ± 4.4 y; and body mass index 
was 32.1 ± 8.3 kg/m2. All 30 study participants were monitored in 
the first stage of labor and 24 in the second stage. The monitoring 
duration per participant was 218 ± 187 min in the first stage and 
91 ± 59 min in the second stage of labor.
TA B L E  1   Summary of Bland-Altman analyses
Parameter Device
n Stage I/
Stage II
LOA  
Stage I
LOA  
Stage II
Bias  
Stage I
Bias  
Stage II
RMSE  
Stage I
RMSE  
Stage II
Baseline rate (bpm) afECG 263/82 −4.4, 4.3 −10.3, 12.1 −0.05 0.90 2.21 4.88
US 228/85 −26.5, 19.1 −31.2, 22.8 −3.70 −4.20 11.40 12.50
STV (ms) afECG 263/82 −3.9, 3.9 −9.7, 7.5 −0.02 −1.10 1.40 2.05
US 228/85 −10.2, 15.0 −15.8, 22.1 2.40 3.10 6.20 8.80
LTV (ms) afECG 263/82 −26.6, 23.3 −67.2, 46.4 −1.60 −10.40 8.70 11.90
US 228/85 −70.5, 111.0 −93.4, 135.9 20.20 21.24 45.90 51.40
Small accelerations 
(No./30 min)
afECG 263/82 −2.8, 2.7 −5.5, 4.0 −0.04 −0.79 1.32 1.90
US 228/85 −3.8, 4.9 −6.6, 8.5 0.56 0.96 2.15 3.80
Large accelerations 
(No./30 min)
afECG 263/82 −2.7, 2.5 −5.3, 3.5 −0.06 −0.89 1.17 1.35
US 228/85 −3.6, 4.8 −6.2, 8.3 0.60 1.05 2.13 3.70
Small decelerations 
(No./30 min)
afECG 263/82 −1.9, 2.0 −3.7, 3.1 0.03 −0.33 0.94 1.40
US 228/85 −3.0, 3.9 −4.1, 5.0 0.48 0.46 1.66 1.99
Large decelerations 
(No./30 min)
afECG 263/82 −0.6, 0.6 −1.8, 1.2 0.00 −0.27 0.31 0.60
US 228/85 −1.5, 1.7 −2.6, 2.2 0.13 −0.19 0.79 0.90
Abbreviations: RMSE, root mean square error; afECG, abdominal-fetal ECG device; US, Doppler ultrasound device; STV, short-term variability; LTV, 
long-term variability; n, number of matched pairs stage I/stage II; LOA, limits of Agreement.
TA B L E  2   Distribution of errors
Parameter afECG US P-value
Baseline FHR (bpm) 
stage I
0 (1) [263] 0 (1) [228] 0.007
Baseline FHR (bpm) 
stage II
0 (2) [82] 0 (6.3) [85] 0.036
STV stage I (ms) 0.07 (1.1) [263] 0.02 (2.8) [228] 0.012
STV stage II (ms) 0.08 (2.1) [82] 0.34 (5.9) [85] 0.002
LTV stage I (ms) 0.16 (3.9) [263] 1.63 (19.7) [228] 0.001
LTV stage II (ms) −0.39 (15.6) 
[82]
5.7 (43.4) [85] 0.001
Small accelerations 
stage I (no./30 min)
0 (1) [263] 0 (1) [228] 0.008
Small accelerations 
stage II (no./30 min)
0 (3) [82] 0 (2) [85] 0.020
Large accelerations 
stage I (no./30 min)
0 (0) [263] 0 (1) [228] 0.001
Large accelerations 
stage II (no./30 min)
0 (1) [82] 0 (2) [85] 0.003
Small decelerations 
stage I (no./30 min)
0 (0) [263] 0 (1) [228] 0.001
Small decelerations 
stage II (no./30 min)
0 (1) [82] 0 (2) [85] 0.003
Large decelerations 
stage I (no./30 min)
0 (0) [263] 0 (0) [228] 0.015
Large decelerations 
stage II (no./30 min)
0 (0) [82] 0 (0.25) [85] 0.255
Note: All results are expressed as median (IQR) [n]. IQR, interquartile 
range; n, number of matched pairs in analysis; STV, short-term 
variability; LTV, long-term variability; P-values from Wilcoxon signed-
rank test comparing the errors between the two monitoring methods. 
The error was the difference between the test device and the scalp 
electrode results.
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F I G U R E  1   (A-D) Bland-Altman plots for baseline fetal heart rate (FHR) in stage I of labor comparing agreement of abdominal-fetal 
electrocardiogram (afECG) method with fetal scalp electrode (FSE) method (A) and ultrasound (US) with FSE (B). Stage II results are also 
shown for afECG (C) and US (D). In both stages the afECG displayed better agreement with the FSE than did US [Color figure can be viewed 
at wileyonlinelibrary.com] [Colour figure can be viewed at wileyonlinelibrary.com]
Modality Parameter
False-negative rate 
(number/30 min)
False-positive rate 
(number/30 min)
Stage I Stage II Stage I Stage II
afECG
n = 263/82
Small accelerations 0.44** 1.18*/** 0.40** 0.39
Large accelerations 0.35** 1.12*/** 0.29** 0.23
Small decelerations 0.25 0.70*/** 0.28** 0.37
Large decelerations 0.04 0.32* 0.04** 0.05
US
n = 228/85
Small accelerations 0.35 0.67* 0.91 1.64*
Large accelerations 0.20 0.48* 0.80 1.53*
Small decelerations 0.25 0.55* 0.74 1.01*
Large decelerations 0.07 0.40* 0.20 0.21
Note: n, number of 30-min frames analyzed in stage I/stage II; afECG, abdominal-fetal ECG method; 
US, Doppler ultrasound method. Data are the mean number of false-positive or false-negative 
accelerations or decelerations per 30-minute frame. A false-positive event is one that occurred 
in the test device but not in the scalp electrode data; a false-negative event was seen in the scalp 
electrode but not in the test device.
*Stage II significantly different from stage I using Z-test. 
**Significantly different from US for same parameter using Z-test. 
TA B L E  3   False-positive and false-
negative periodic event rates
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The results of all Bland-Altman analyses are summarized in Table 1. 
For each comparison, afECG gave results closer to those of the FSE than 
did US. Results of the comparison of the error distributions (Wilcoxon 
test) are shown in Table 2. For each parameter, with the exception of iden-
tifying large decelerations in the second stage, afECG was superior to US.
3.2 | Baseline rate
The spread of average baseline heart rate values around the nearly 
horizontal Bland-Altman regression line is quite narrow for afECG, as 
can be seen visually (Figure 1A) and confirmed by the minimal bias, 
narrow limits of agreement, and small root mean square error (Table 1). 
When, however, US was compared with the FSE the results were quite 
different (Figure 1B). The spread of values around the regression line 
was substantially greater, with wider limits of agreement, and greater 
bias and root mean square error. An error of more than 10 bpm oc-
curred only 1.0% of the time with afECG; it occurred about 14% of the 
time with US. These differences were similarly distributed in stages 
I and II of labor (Figures 1C and 1D). For each comparison of errors 
(the difference between paired external and FSE-derived heart rates), 
the differences between the afECG and US baseline FHR values were 
statistically significant (Table 2).
3.3 | Variability
For measures of both STV and LTV, the difference between the 
external method and the FSE-derived variability was substantially 
greater for the US than the afECG method, differences most evident 
at diminished variability levels, when error has the greatest clinical 
importance. This was true in both first and second stages of labor. 
When the STV from the FSE was low (<5.0 ms) the afECG error re-
mained stable, but the US error increased considerably (Figures 2–3). 
The Bland-Altman LTV plots (Figures 3A–3D) were similar to those 
for STV in that the afECG error was minimal for low values of LTV.
3.4 | Accelerations and decelerations
The afECG method identified periodic small and large accelera-
tions and small decelerations with greater reliability than did US 
F I G U R E  2   (A-D) Bland-Altman plots for short-term variability (STV) in stage I of labor comparing agreement of abdominal-fetal 
electrocardiogram (afECG) method with fetal scalp electrode (FSE) method (A) and Doppler ultrasound (US) with FSE (B). Stage II results are 
also shown for aFECG (C) and US (D). In both stages the afECG displayed better agreement with the FSE than did US [Color figure can be 
viewed at wileyonlinelibrary.com]
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in both stage I and stage II of labor. That is to say, the differences 
in the error frequencies between the external monitoring modes 
and the FSE were statistically significant, and Bland-Altman pat-
terns of agreement showed a wider spread around the regression 
line for US than for afECG (Table 1). Large deceleration identifica-
tions in stage I showed that the errors between afECG and the 
FSE were smaller than those between US and the FSE (P = 0.015) 
(Table 2); however, for stage II they were not significantly different 
(P = 0.255).
Figures 4A–4D indicate the large deceleration error count as a 
function of frame number, demonstrating false positive identifi-
cations in Stages I and II for afECG and US. These results (Table 3) 
demonstrate overall a low rate of false events for both external mon-
itoring methods, generally lower than 2 per 30 minutes. For both 
methods, the false-negative and false-positive rates were signifi-
cantly higher in the second stage than in the first. afECG had a sig-
nificantly higher rate of false-negative accelerations in both labor 
stages, and a higher false-negative rate for small decelerations in the 
second. False-positive accelerations and decelerations were signifi-
cantly more common during the first stage with US than with afECG 
monitoring.
4  | DISCUSSION
We found the computerized identification of FHR characteristics 
for the afECG technique was in most instances more faithful to re-
sults from the scalp electrode than US-based FHR detection in the 
identification of baseline heart rate, and heart rate variability, ac-
celerations, and decelerations. These results considerably expand 
our understanding of afECG-derived FHR patterns. Although the 
high accuracy and reliability of this technique in recognizing fetal 
cardiac activity was demonstrated previously, we have now shown 
that fundamental characteristics of heart rate patterns used in as-
sessment of the fetus (rate, variability, periodic changes) are readily 
recognizable when using an afECG system. This system, therefore, 
proved equivalent or superior to US in replicating heart rate patterns 
derived from an FSE.
Our results have important clinical implications. Current rec-
ommendations for the clinical assessment of variability in the 
interpretation of FHR patterns require making fine distinctions 
in the degree of variability observed. Because such distinctions 
have a potentially substantial influence on decision-making, and 
because they are a component of all extant systems for FHR 
F I G U R E  3   (A-D) Bland-Altman plots for long-term variability (LTV) in stage I of labor comparing agreement of abdominal-fetal 
electrocardiogram (afECG) method with fetal scalp electrode (FSE) method (A) and Doppler ultrasound (US) with FSE (B). Stage II results are 
also shown for aFECG (C) and US (D). In both stages the afECG displayed better agreement with the FSE than did US [Color figure can be 
viewed at wileyonlinelibrary.com]
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pattern interpretation,28-30 it is critically important that the tech-
nique used to assess rate and variability provide the most accurate 
available information. It has been assumed since the introduction 
of autocorrelation techniques to cardiotachometer software that 
US-derived FHR patterns can be assumed to display true FHR 
variability. Although this may be a reasonable generalization, it is 
not always correct.31-34 On the contrary, our results show that the 
representation of FHR variability may be altered considerably by 
US-based monitoring, and should be interpreted with considerable 
caution. Moreover, the situations in which US is most likely to ex-
aggerate true variability are those in which it is actually diminished, 
potentially leading to false reassurance and failure to timely inter-
vention. If an external FHR monitoring technique is chosen, afECG 
will depict STV and LTV more accurately than will US techniques.
Our results also indicate that the clinician can be confident 
that periodic changes in the heart rate pattern—accelerations and 
decelerations of various descriptions—will be as recognizable with 
afECG-derived monitoring as with US. In fact, the error in identifying 
accelerations and decelerations was consistently smaller with afECG.
A large randomized trial would be necessary to determine 
whether use of this kind of monitoring technique results in neonatal 
outcomes that are equivalent or superior to monitoring with tradi-
tional US-derived heart rate patterns.
This is the first study to address whether afECG monitoring 
produces FHR patterns that would be interpreted in the same 
manner as those produced by US-based cardiotachometry. Of 
concern in designing this study was the fact that there is consid-
erable inter- and intra-observer variation in the visual interpre-
tation of FHR patterns.35,36 We addressed this potential pitfall 
by using an established electronic means to identify FHR char-
acteristics. This substituted an objective and completely uniform 
diagnostic tool for the inherent subjectivity of human visual 
interpretation.
This was a secondary analysis of a portion of data from a previ-
ously published study. The parent study was not designed or pow-
ered to address the specific hypothesis of this analysis. Nevertheless, 
we had a substantial number of observations, and almost all our 
results were statistically significant. This approach to FHR analysis 
does not distinguish among various types of decelerations, as visual 
observation can, and not every practitioner would agree with all fea-
tures of the algorithm we used for FHR pattern identification. That 
notwithstanding, it provided us with a purely objective and unbiased 
F I G U R E  4   (A-D) Large deceleration error count as a function of frame number for abdominal-fetal electrocardiogram (afECG) (A and C) 
and ultrasound (US) (B and D) for both stages I and II. afECG shows consistently lower error count than US [Color figure can be viewed at 
wileyonlinelibrary.com]
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means of analyzing and comparing the outputs of the three modes 
of monitoring used in the study.
Another potential limitation was the fact that the US device 
was evaluated and adjusted (if necessary) every 20–30 minutes, 
and we did not document the number of adjustments made in each 
participant. This could have resulted in misdirected insonation and 
the potential for error in the inter-evaluation intervals, reinforcing 
the dangers of relying on US-derived measures of fetal well-being 
in a busy ward. This issue is not a concern with afECG monitoring, 
where the electrodes do not require adjustment during the entire 
labor, presenting the medical team with increased time to care for 
the mother rather than the electronic fetal monitoring instrument.
5  | CONCLUSION
We conclude that the afECG-based technique for continuous FHR 
monitoring is an appropriate choice for noninvasive monitoring. The 
heart rate patterns it generated were interpretable, and were gener-
ally superior to those produced by a traditional US method in terms 
of their conformity with patterns derived from a direct fetal elec-
trode. The observed differences were generally of sufficient magni-
tude to influence the clinical interpretation of FHR patterns.
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